Assessment of healthcare technology and economics can be used to assess the access to healthcare, its quality and efficacy as well as its cost and cost efficiency. This report addresses these issues for the provision of care for end-stage renal disease (ESRD) patients. An international comparison of access to ESRD treatment modalities was made with reference to the healthcare provider structure...

BACKGROUND The prevalence of chronic kidney disease (CKD) is high, especially among older patients. METHODS In order to identify risk factors for the evolution towards end-stage renal disease (ESRD), a cohort of patients ≥ 50 years of age for whom at least four serum creatinine measurements were available were selected from a primary care-based database. The slope of changes in estimated glom...

BACKGROUND Acute kidney injury (AKI) after cardiac surgery is associated with increased morbidity and mortality. The long-term association between AKI and end-stage renal disease (ESRD) in an Asian population is unknown. Given the high prevalence of diabetes and a younger age of presentation for cardiac surgery, it is important to track this progression of kidney disease. Therefore, we studied ...

END-STAGE RENAL DISEASE The number of patients enrolled in Medicare’s end-stage renal disease (ESRD) program has increased in near-exponential fashion over the past 30 years — from approximately 10 000 beneficiaries in 1973, to more than 86 000 in 1983, to an estimated 400 000 in 2003. As documented by data from the US Renal Data System (USRDS), about 100 000 new patients with ESRD enter the pr...

Oligomeganephronia is classified as a subgroup of renal hypoplasia, characterized by histopathologic abnormalities which progress to end-stage renal disease (ESRD) by school age. We describe three adult cases of oligomeganephronia who have not yet developed ESRD. We performed a renal biopsy in all of them. The pathological features, consisting of a reduced number of enlarged glomeruli, were dia...

The need for palliative care for patients with end-stage renal disease (ESRD) is increasingly recognized. Patients starting renal replacement therapy are now elderly, with a median age of 65 years, and with multiple comorbid conditions. Quality of life is often poor and with advance care planning, patients can be enabled to make the choice of stopping or not starting dialysis. With planned end-...

End-stage renal disease (ESRD) has been a widespread disease in many countries, especially in Taiwan. According to the statistics of United States renal data system (USRDS), Taiwan had high rates of incident ESRD and the greatest rates of prevalent ESRD in 2008. Moreover, with the increasing ESRD patients appear, the huge expense becomes a heavy burden in the society. To avoid deterioration, th...

Familial LCAT deficiency (FLD) is a recessive lipid disorder ultimately leading to end-stage renal disease (ESRD). We present two brothers with considerable variation in the age at which they developed ESRD. Kidney biopsies revealed both tubular and glomerular pathology. To date, no causal therapy is available, yet enzyme replacement therapy is in development.